Cue Biopharma (CUE) Current Assets (2016 - 2026)
Cue Biopharma (CUE) reported Current Assets of $26.62 million for Q2 2026, down 13.7% from $30.84 million a year earlier.
Powered by 
Analysis
Cue Biopharma (CUE) Current Assets (2016 - 2026) Analysis & Trends
At the end of FY2025, Cue Biopharma posted Current Assets of $36.98 million, up 47.1% from FY2024.
- Current Assets has a five-year compound annual growth rate of -15.8% (FY2020 to FY2025).
- By year, Current Assets came in at $25.14 million in FY2024 (-51.1%), $51.45 million in FY2023 (-33.3%), $77.19 million in FY2022 (+12.7%) and $68.47 million in FY2021 (-21.8%).
- Five-year quarterly Current Assets spans a low of $15.93 million in Q1 2025 and a high of $77.19 million in Q4 2022.
- Year over year, Current Assets gained in 1 of the last seven quarters, with an average decline of 22.4%.
- The high point for year-over-year Current Assets in five years was Q4 2025 (growth of 47.1%); the low point was Q1 2025 (a decline of 64.3%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 65.26 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 56.35 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 37.48 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 38.94 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 31.45 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 34.36 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 16.55 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 45.01 Bn |
| 10 | Cue Biopharma | 98.10 Mn | 18.47 Mn | - | 26.62 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 26.62 Mn |
| Mar 31, 2026 | 26.39 Mn |
| Dec 31, 2025 | 36.98 Mn |
| Sep 30, 2025 | 25.82 Mn |
| Jun 30, 2025 | 30.84 Mn |
| Mar 31, 2025 | 15.93 Mn |
| Dec 31, 2024 | 25.14 Mn |
| Sep 30, 2024 | 37.26 Mn |
| Jun 30, 2024 | 33.90 Mn |
| Mar 31, 2024 | 44.67 Mn |
| Dec 31, 2023 | 51.45 Mn |
| Sep 30, 2023 | 57.52 Mn |
| Jun 30, 2023 | 60.94 Mn |
| Mar 31, 2023 | 68.76 Mn |
| Dec 31, 2022 | 77.19 Mn |
| Sep 30, 2022 | 61.70 Mn |
| Jun 30, 2022 | 69.00 Mn |
| Mar 31, 2022 | 75.95 Mn |
| Dec 31, 2021 | 68.47 Mn |
| Sep 30, 2021 | 70.26 Mn |
API Access
Cue Biopharma Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=CUE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "CUE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=CUE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();